{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:03:00Z","timestamp":1789970580949,"version":"4.0.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017438","name":"Government of Xinjiang Uygur Autonomous Region of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To characterise antimicrobial resistance phenotypes,\n                      <jats:italic>in vitro<\/jats:italic>\n                      susceptibility to four commonly used disinfectants, and the distribution of resistance-associated genes among clinical carbapenem-resistant Pseudomonas aeruginosa (CRPA) isolates from two tertiary hospitals in Urumqi, China, in order to provide local surveillance evidence to inform antimicrobial stewardship and infection prevention and control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Eighty nonduplicate CRPA isolates were consecutively recovered from clinical specimens at two tertiary hospitals in Urumqi between January 2025 and March 2026. Antimicrobial susceptibility was determined using the VITEK 2 system, with disk diffusion performed when confirmatory testing was required, and interpreted according to CLSI M100-S31 (2021). Carbapenemase production was assessed by the modified carbapenem inactivation method (mCIM). A broth microdilution assay adapted from antimicrobial susceptibility testing, and not a standardised biocide efficacy test, was used to compare minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of benzalkonium bromide, ethanol, povidone-iodine, and a chlorine-containing disinfectant between isolate groups. Polymerase chain reaction (PCR) was performed to detect carbapenem resistance-associated genes\n                      <jats:italic>(blaKPC, blaNDM, oprD, blaOXA-10, blaOXA-48, blaVIM, blaIMP<\/jats:italic>\n                      ) and disinfectant resistance genes (\n                      <jats:italic>aceI, emrE, merA, qacE\u03941-sul1, tehA, oqxA<\/jats:italic>\n                      ). Outcomes were organised into one primary and three exploratory families, with Holm and Benjamini\u2013Hochberg correction applied within families respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 80 CRPA isolates, 24 (30.00%) were extensively drug-resistant (XDR) and 56 (70.00%) were non-XDR. Resistance rates to imipenem and meropenem were 83.70% and 68.70% respectively, and no isolate was susceptible to either agent. Overall resistance rates to aztreonam, piperacillin\/tazobactam, levofloxacin, ceftazidime, cefepime, amikacin, and tobramycin were 37.50%, 30.00%, 26.30%, 25.00%, 21.30%, 12.50%, and 6.30% respectively. The expected oprD amplicon failed to amplify in 55 isolates (68.75%). mCIM was positive in 23 isolates (28.75%), with 95.0% agreement with PCR-detected carbapenemase gene carriage (Cohen\u2019s \u03ba 0.871, 95% CI 0.748\u20130.994). Detection rates for\n                      <jats:italic>blaKPC, blaNDM, blaVIM, and blaIMP<\/jats:italic>\n                      were 10.00%, 6.25%, 5.00%, and 2.50% respectively; neither\n                      <jats:italic>blaOXA-10<\/jats:italic>\n                      nor\n                      <jats:italic>blaOXA-48<\/jats:italic>\n                      was detected.\n                      <jats:italic>qacE\u03941-sul1, merA, tehA, and oqxA<\/jats:italic>\n                      were detected in 36.25%, 16.25%, 7.50%, and 2.50% of isolates respectively, whereas aceI and\n                      <jats:italic>emrE<\/jats:italic>\n                      were not detected. For ethanol the MIC50 and MIC90 were 75% (v\/v) in both groups; for the chlorine-containing disinfectant and povidone-iodine the MIC50\/MIC90 were 512\/1024 mg\/L in both groups, and neither MICs nor MBCs differed between groups. Benzalkonium bromide MICs ranged from 32 to 256 mg\/L in XDR and 16 to 256 mg\/L in non-XDR isolates, and MBCs from 64 to 512 and 64 to 256 mg\/L respectively; the MIC difference was the primary outcome and remained significant after Holm correction (adjusted P &amp;lt; 0.001), whereas the MBC difference did not survive correction when considered alongside the other disinfectant endpoints (Benjamini\u2013Hochberg q=0.144). qacE\u03941-sul1 was more frequent among XDR isolates in unadjusted analysis (58.3% versus 26.8%; OR 3.83, 95% CI 1.40\u201310.45; unadjusted P = 0.011) but did not retain significance after correction within the eight-test gene family (q = 0.088). Resistance to aztreonam and meropenem was nominally more frequent among\n                      <jats:italic>qacE\u03941-sul1<\/jats:italic>\n                      -positive isolates (55.20% versus 27.50% and 86.2% versus 58.80%) but neither association survived correction (q=0.072 for both; Holm-adjusted P = 0.111 and 0.100). Direct comparison of benzalkonium bromide endpoints by qacE\u03941-sul1 status showed no difference (median MIC 64 mg\/L in both groups, P = 0.097; median MBC 128 mg\/L in both groups, P = 0.697).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      CRPA isolates from these two hospitals showed uniform nonsusceptibility to carbapenems, with failure to amplify the expected oprD target the most frequent molecular observation. XDR isolates showed higher benzalkonium bromide MICs\n                      <jats:italic>in vitro<\/jats:italic>\n                      compared with non-XDR isolates. qacE\u03941-sul1 was the predominant disinfectant resistance gene detected, but its association with the XDR phenotype did not survive correction for multiple comparisons, and carriage was not accompanied by any measurable difference in benzalkonium bromide susceptibility. These findings provide baseline epidemiological data for Urumqi, though whole-genome sequencing, molecular typing, expression analysis, and standardised biocide efficacy testing would be required to establish mechanistic determinants.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1938496","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:08Z","timestamp":1789968968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance phenotypes, disinfectant susceptibility, and resistance-associated gene detection in carbapenem-resistant Pseudomonas aeruginosa from two tertiary hospitals in Urumqi, China"],"prefix":"10.3389","volume":"16","author":[{"given":"Ping","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Medical Administration, The Fifth Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]},{"name":"Xinjiang Regional Population Health Research Center","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Niu","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adila","family":"Maimaiti","sequence":"additional","affiliation":[{"name":"College of Nursing, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B27","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1186\/s12879-024-10123-7","article-title":"Prevalence of blaOXA-48 and other carbapenemase encoding genes among CRPA","volume":"24","author":"Abdelraheem","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jgar.2023.12.029","article-title":"Molecular epidemiological characteristics of CRPA clinical isolates in southeast Shanxi, China","volume":"36","author":"Bai","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2025.104523","article-title":"Increased rates of blaNDM in Pseudomonas aeruginosa in a tertiary care hospital in southern Brazil","volume":"29","author":"Barth","year":"2025","journal-title":"Braz. J. Infect. Dis."},{"key":"B26","first-page":"886","article-title":"Prevalence of antibiotic resistance determinants in CRPA","volume":"14","author":"Behboudipour","year":"2025","journal-title":"Int. J. Mol. Cell. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jgar.2019.01.016","article-title":"Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a CRPA clinical isolate","volume":"17","author":"Bocharova","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s15010-024-02483-2","article-title":"In vivo divergent evolution of cross-resistance to new \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Pseudomonas aeruginosa","volume":"53","author":"Cai","year":"2024","journal-title":"Infection"},{"key":"B35","first-page":"364","article-title":"Analysis on clinical distribution and drug resistance of MDR bacteria infection in non-ICU wards from 2020 to 2023","volume":"32","author":"Du","year":"2025","journal-title":"Chin. J. Prim Med. Pharm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/s1473-3099(13)70168-3","article-title":"Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia","volume":"13","author":"Edelstein","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B14","first-page":"302","article-title":"Isolation of Salmonella serotypes in wastewater and efficacy of neutralizing agents for disinfectant residues","volume":"53","author":"Espigares","year":"2003","journal-title":"J. Hosp. Infect."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13020191","article-title":"Molecular analysis of carbapenem and aminoglycoside resistance genes in CRPA","volume":"13","author":"Gondal","year":"2024","journal-title":"Antibiotics"},{"key":"B22","first-page":"91","article-title":"Molecular epidemiological study of carbapenem-resistant Acinetobacter baumannii in ICU","volume":"12","author":"Guo","year":"2019","journal-title":"Chin. J. Crit. Care Med."},{"key":"B20","first-page":"1087","article-title":"Analysis on distribution and drug resistance of carbapenem-resistant gram-negative bacilli in a hospital from 2021 to 2023","volume":"30","author":"Huang","year":"2024","journal-title":"Int. Med. Health Guidance"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2026.04.008","article-title":"Genomic insights into a multidrug-resistant P. aeruginosa ST463 clinical isolate co-harbouring blaKPC-2 and blaNDM-9","author":"Huang","year":"2026","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00213-21","article-title":"Overview of changes to the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing, M100, 31st edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2026.123740","article-title":"Genomic determinants across cross- and co-resistance events of the environmental resistome of K. pneumoniae","volume":"293","author":"Kayet","year":"2026","journal-title":"Environ. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1007\/s11033-022-07640-6","article-title":"Molecular characterization of CRPA isolated from four medical centres in Iran","volume":"49","author":"Khalili","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"B12","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. 35th Ed. CLSI Supplement M100","author":"Lewis","year":"2025"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107466","article-title":"The evolution of CRPA in the COVID-19 era: a global perspective and regional insights","volume":"65","author":"Li","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B17","first-page":"2026","article-title":"Evaluation of co-resistance rates and patient outcomes in multidrug-resistant Pseudomonas aeruginosa","volume":"13","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"B18","first-page":"18","article-title":"Study on disinfectant resistance genes and disinfectant resistance in carbapenem-resistant non-fermentative bacteria","volume":"22","author":"Liang","year":"2025","journal-title":"China Med. Herald"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1099\/jmm.0.000403","article-title":"Frequency of disinfectant resistance genes and reduced susceptibility to disinfectants in carbapenem-resistant Acinetobacter baumannii","volume":"66","author":"Liu","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106397","article-title":"Effect of piperine on the inhibitory potential of MexAB-OprM efflux pump and imipenem resistance in CRPA","volume":"185","author":"Liu","year":"2023","journal-title":"Microb. Pathog."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107017","DOI":"10.1016\/j.mimet.2025.107245","article-title":"Efficacy of different \"boiling\" methods for bacterial DNA extraction","volume":"228","author":"Loberiza","year":"2025","journal-title":"J. Microbiol. Methods"},{"key":"B19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/antibiotics15010102","article-title":"Molecular epidemiology of CRPA before the COVID-19 pandemic","volume":"15","author":"Loredo-Puerta","year":"2026","journal-title":"Antibiotics"},{"key":"B32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/mdr.2024.0059","article-title":"Characterization of the chromosomally located MBL genes blaIMP-45 and blaVIM-2 in a CRPA clinical isolate","volume":"30","author":"Ma","year":"2024","journal-title":"Microb. Drug Resist."},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3855\/jidc.19953","article-title":"Molecular study of CRPA causing wound infection in an Egyptian tertiary hospital","volume":"19","author":"Menofy","year":"2025","journal-title":"J. Infect. Dev. Ctries"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060736","article-title":"Disinfection strategies for carbapenem-resistant Klebsiella pneumoniae in a healthcare facility","volume":"11","author":"Ni","year":"2022","journal-title":"Antibiotics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jgar.2022.04.008","article-title":"Isolation and characterisation of CRPA from hospital environments in tertiary care hospitals in Dhaka, Bangladesh","volume":"30","author":"Saha","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B33","first-page":"38","article-title":"Molecular epidemiology of colistin-resistant CRPA producing NDM-1","volume":"22","author":"Farajzadeh Sheikh","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jam.14158","article-title":"Impact of triclosan adaptation on membrane properties, efflux and antimicrobial resistance of E. coli clinical isolates","volume":"126","author":"Sonbol","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1556\/030.2024.02309","article-title":"Genomic insights into NDM-1-producing CRPA","volume":"71","author":"Strateva","year":"2024","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"B34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cmi.2025.12.011","article-title":"Emergence of cefiderocol resistance mediated by blaAFM-1 overexpression and FptA mutations in clinical CRPA isolates","volume":"32","author":"Xiao","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"107703","DOI":"10.1016\/j.ijantimicag.2025.107703","article-title":"Development of ceftazidime-avibactam resistance driven by conversion of blaKPC-2 to blaKPC-78 during treatment of ST463 CRPA infection","volume":"67","author":"Xu","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01669-23","article-title":"Nationwide genome surveillance of carbapenem-resistant Pseudomonas aeruginosa in Japan","volume":"68","author":"Yano","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1280012","article-title":"Evaluation of multidrug resistance and hypervirulence-associated genes among CRPA strains in children","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/mdr.2024.0089","article-title":"Determining the disinfectant resistance genes and the susceptibility to common disinfectants of XDR CRKP strains","volume":"30","author":"Zhao","year":"2024","journal-title":"Microb. Drug Resist."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1938496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:11Z","timestamp":1789968971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1938496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2026.1938496"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1938496","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1938496"}}